Research provides reassurance about the safety of testosterone treatment

Treatment with testosterone (the primary male sex hormone) does not increase the risk of heart attack, stroke or other diseases of the heart and blood vessels (cardiovascular disease), research found. The treatment was safe when given for less than a year to men with low levels of testosterone ( 2 External 0 0 0 hypogonadism false https://www.nhs.uk/conditions/male-menopause/#:~:text=Hypogonadism%20is%20sometimes%20present%20from,the%20%22male%20menopause%22%20symptoms. false false%>). Longer term follow up is ongoing. Men with hypogonadism can experience loss of muscle mass, sexual problems, and reduced quality of life. Testosterone treatment can successfully address these changes. However, many doctors are reluctant to prescribe this treatment because of concerns about its safety. In a large analysis of safety data on testosterone treatment, researchers found no evidence that testosterone increased cardiovascular problems in the short- to medium-term. Few men died when receiving treatment. There were no groups (such as elderly men) at increased risk of cardiovascular events such as heart attacks.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news